pixantrone has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dubois, B; Gonsette, RE | 1 |
Aldinucci, A; Ballerini, C; Biagioli, T; Cavaletti, G; Cavalletti, E; Frigo, M; Lolli, F; Massacesi, L; Mazzanti, B; Oggioni, N; Riccio, P; Rota, S; Tagliabue, E | 1 |
1 review(s) available for pixantrone and Disease Models, Animal
Article | Year |
---|---|
Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity.
Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Heart; Humans; Immunosuppressive Agents; Immunotherapy; Isoquinolines; Mitoxantrone; Multiple Sclerosis | 2004 |
1 other study(ies) available for pixantrone and Disease Models, Animal
Article | Year |
---|---|
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis.
Topics: Analysis of Variance; Animals; Antibodies; Antigens, CD; Apoptosis; B-Lymphocytes; Cell Proliferation; Cytokines; Cytokinesis; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunosuppressive Agents; Isoquinolines; Myelin Basic Protein; Rats; Rats, Inbred Lew; T-Lymphocytes; Time Factors | 2005 |